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Abstract
Background: Coxiella burnetii is the causative agent of the zoonotic disease Q fever. As it is an intracellular pathogen,
infection by C. burnetii requires adaptation to its eukaryotic host and intracellular environment. The recently developed
cell-free medium also allows the bacteria to propagate without host cells, maintaining its infection potential. The
adaptation to different hosts or extracellular environments has been assumed to involve genome-wide modulation of
C. burnetii gene expression. However, little is currently known about these adaptation events which are critical for
understanding the intracellular survival of C. burnetii.
Results: We studied C. burnetii genome–wide transcriptional patterns in vivo (mice spleen) and in cell and cell-free in
vitro culture models to examine its metabolic pathways and virulence associated gene expression patterns that are
required to colonize and persist in different environments. Within each model, the gene expression profiles of
the Dutch C. burnetii outbreak strain (602) and NM reference strains were largely similar. In contrast, modulation
of gene-expression was strongly influenced by the cultivation method, indicating adaptation of the bacterium to
available components. Genome–wide expression profiles of C. burnetii from in vitro cell culture were more similar
to those seen for in vivo conditions, while gene expression profiles of cell-free culture were more distant to in vivo.
Under in vivo conditions, significant alterations of genes involved in metabolism and virulence were identified.
We observed that C. burnetii under in vivo conditions predominantly uses glucose as a carbon source (mostly for
biosynthetic processes) and fatty acids for energy generation. C. burnetii experienced nutrient limitation and
anaerobiosis as major stressors, while phosphate limitation was identified as an important signal for intracellular
growth inside eukaryotic host cells. Finally, the in vivo environment significantly induced expression of several
virulence genes, including those implicated in LPS synthesis, colonization, host component modulation and DNA
repair mechanisms.
Conclusion: Our study shows that C. burnetii, with its relative small genome, requires only a subset of core gene
functions to survive under in vitro conditions, but requires the induction of full repertoire of genes for successful
pathogenesis and thriving in harsh environments in vivo.
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Background
Q fever, a worldwide zoonotic infectious disease, is
caused by Coxiella burnetii, an intracellular Gram nega-
tive bacterium. Domestic ruminants (e.g., goat, sheep
and cattle) are considered the main reservoir for Q fever
infections in humans; the bacterium can cause a range
of diseases depending on the host [1–3]. The main clin-
ical manifestation of Q fever in goats and sheep are
abortions, which result in the shedding of large numbers
of bacteria into the environment. Inhalation of such con-
taminated aerosols is the main route of transmission in
humans and can lead to acute or chronic Q fever [1, 4].
Acute infections range from asymptomatic to abrupt flu-
like illness or pneumonia [5]; chronic infection is typic-
ally manifested as endocarditis [6]. An unprecedented
outbreak of Q fever occurred in the Netherlands during
the years 2007–2010, with more than 4000 human cases
registered; infected dairy goats and sheep were identified
as the primary source of the disease [7–11].
Attempts to understand the biology and pathogenesis
of this bacterium through molecular techniques have
been hampered by its intracellular lifestyle. However, a
better understanding of the interactions of the pathogen
with the host could be gained using global transcription
profiles. This might aid in determining adaptations of
the bacterium within the infected host and provide a
fuller appreciation of its pathogenicity.
As an obligate intracellular pathogen, C. burnetii re-
sides and proliferates within the acidic parasitophorous
vacuole (PV) of the host cells [12]. The bacteria can in-
fect a wide range of hosts and can also propagate to high
quantities in different in vitro culture models [1, 13–15].
Within a laboratory setup, immune-competent mice are
usually used as the in vivo animal model to assess the in-
fection potential of C. burnetii [16]. The virulence of the
strains is often measured based on splenomegaly and
load of the bacteria in the spleen of mice [17–19]. C.
burnetii are routinely cultured in BGM cells [15, 20],
Vero cells [21] or macrophage like cell lines [12, 22].
The bacterium can establish persistent infections in cell
culture, where it multiplies and survives in the cell PV.
The latest advancement in Q fever research is the de-
velopment of a host cell-free medium, designed based
on the metabolic requirements of the bacterium. This
complex nutrient medium supports substantial growth
of most C. burnetii isolates and overcomes the draw-
backs encountered when studying the pathogen in cell
based culture or in vivo models [14, 15, 23].
Availability of complete genome sequences of C. burnetii
contributed significantly towards understanding of the
physiology and the pathogenic abilities of the bacterium
[24]. However, information regarding environmental adap-
tations and expression of potential virulence factors
important for bacterial colonization, replication and
persistence under in vivo and in vitro systems is not
entirely clear. Such information will provide insights into
processes occurring during intracellular and extracellular
growth of C. burnetii and allow direct evaluation of the
relationship between gene expression patterns during
growth inside living hosts and under in vitro conditions.
In this study, we endeavour to understand how the
pathogen adapts to the host microenvironment, by moni-
toring the expression changes across the whole transcrip-
tome of C. burnetii obtained within different propagation
models. Main reservoirs of Q fever, such as pregnant goat
and sheep, harbor the pathogen primarily in placentas,
making this an ideal in vivo sample [20]. The bacterium
has also been detected in oviducts and genital tissues of
naturally infected non-pregnant goats [25]. However, use
of these models to assess in vivo C. burnetii global tran-
scriptional profiles is hampered by technical difficulties re-
garding the required fresh aborted sample collection
(placentas), low RNA concentrations and quality. To avoid
these limitations we used the spleens of experimentally in-
fected mice as an in vivo model. We report here the global
transcriptional pattern of C. burnetii from this in vivo
model (mice spleen) compared with C. burnetii grown
under laboratory conditions using cell-based and cell-free
culture methods. In addition, we allowed strains to adapt
from cell to cell-free culture propagation and considered
the first two passages to determine the adaptation capabil-
ities of the bacterium as it moves from one environment
(propagation inside host cells) to another (cell-free cul-
tivation). Our study provides a comprehensive view of
C. burnetii metabolic adaptations and other important
process required for its survival in response to diverse
environments.
Results and discussion
Preparation of C. burnetii cells from different propagation
models and measurement of its gene expression patterns
A whole-genome microarray was constructed based on all
the available annotated genome sequences of C. burnetii
in the databases. The mRNA levels of the expressed genes
were assessed under in vivo and various in vitro condi-
tions. For the in vivo transcriptome analysis, C. burnetii
obtained from infected mice spleens were chosen, as
spleens are highly responsive to infections and bacterial
colonization in spleen is a good indicator of infectivity and
persistence over time [17–19, 26]. During the time of sam-
pling, all infected mice showed splenomegaly and an al-
most 10 fold increase in number of bacteria in the spleen.
This spleen mice model offers several benefits, although it
also has limitations, such as the usage of intraperitoneal
(IP) infection route rather than intranasal route which is
the best natural exposure model. However, because no
significant changes in splenomegaly or bacterial numbers
in spleens were observed between different inoculation
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routes, the IP route seems an easy and efficient inocula-
tion route for C. burnetii infections in mice [27]. We de-
termined the global transcriptional patterns of C. burnetii
at 20 days p.i, because host immune responses towards
bacterial infection were high around this period (data not
shown) allowing us to examine bacterial metabolic adapta-
tions, role of virulence factors and mechanisms to evade
host defenses. C. burnetii infection in mice usually results
in higher bacterial numbers in spleen at early infection
stages (7–14 days) followed by significant decrease in bac-
teria around 20 days. This most likely indicates an influx
of immune (T) cells into the spleen around 7 days p.i.,
resulting in increased splenomegaly and facilitating bacter-
ial clearance thereafter [17]. To obtain sufficient bacterial
RNA from spleens at day 20, a higher dose of bacteria (107
genome equivalents) were inoculated in our mice. This
high dosage was checked in our previous study, which
showed that for mice given this dosage, splenomegaly and
bacterial replication rate patterns at different time periods
(Additional file 1: Figure S1) were similar to a lower dos-
age (104 genome equivalents) [26]. Transcriptional profiles
of C. burnetii from later stage of infection (20 days), where
the bacterial numbers are significantly lower than at early
infection stages, were compared with stationary phases
of in vitro grown bacterium (cell and cell-free cultures)
to examine environmentally-linked gene expression dif-
ferences of the bacterium. To further study the various
adaptations of the bacterium, C. burnetii propagated from
first two serial passages in cell-free culture (p1 and p2)
from cell-cultured strains and (fully) adapted cell-free cul-
tured strains from stationary phase were considered. Gene
expression of all cell-free cultured strains (p1, p2 and
adapted) was compared with gene expression from cell
culture as reference.
Impact of cultivation conditions on C. burnetii
transcriptome
Good quality RNA was isolated from C. burnetii origin-
ating from different culture systems by depletion of the
host RNA (except in cell-free culture system). The RNA
was successfully labelled and used for microarray ana-
lysis (in triplicate). Principal component analysis (PCA)
plots were constructed, which clearly showed that most
sample triplicate clustered tightly, indicative of good ex-
perimental reproducibility of samples for each strain in
different culture systems (Fig. 1).
Niche specific gene expression patterns of C. burnetii
To get an overview of the gene expression of 602 and NM
strains induced by different culture models, hierarchical
clustering was performed based on average normalised
signal intensity of probes. Clustering showed that the ex-
pression profiles of strains are largely determined by the
method in which they were cultured or isolated (Fig. 2).
Fig. 1 Principal component analysis on genome-wide expression profiles of C. burnetii strains 602 and NM obtained from various culture systems.
Triplicate findings for each sample from different culture systems are clustered together indicative for experimental reproducibility. The plots of
independent samples demonstrate also that based on their transcriptome profile, samples from different culture models can be differentiated
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The expression profiles of C. burnetii isolated from in vivo
and in vitro models clustered separately. Within the in vitro
culture models, expression profiles of strains from cell cul-
ture were closer to the in vivo model, followed by expres-
sion profiles of strains obtained from the cell-free culture
model. These results suggest that gene expression of C.
burnetii depends on the available components present
in the growth medium, tissue or cell. Hence, the possible
differences in the metabolic capabilities of the strains are
clearly seen in culture models considered in the study.
The global transcription profile in different culture
models
Because the different strains have transcriptional profile
clustering based on the culture model in which it was
propagated, thorough studies of gene expression were
conducted. We determined which genes showed major
differential expression in the spleens of mice compared
to in vitro models. Moreover, we looked into differences
in gene expression that existed between in vitro culture
models. These detailed studies were conducted using the
data from the Dutch outbreak strain 602, which was
shown to be highly virulent by our previous mouse viru-
lence bioassays [15]. Genespring microarray software
analysis showed 906 of the 2061 genes were, compared
to in vitro cell culture, differentially regulated (p < 0.05,
fold change of 2) in 602 strains from mice spleen, with a
majority of genes (67 %) up-regulated. Comparing ex-
pression profiles of the 602 strain under in vitro condi-
tions (cell-free vs. cell culture model) showed that 438
genes were differentially regulated, but the majority of
genes (71 %) were down-regulated. A complete microarray
dataset from the different comparisons are presented as
supplementary material (Additional file 2: Table S1).
Next, in various growth models, we determined the
functional categories [28] and performed pathway en-
richment analysis of the differentially regulated genes
(Fig. 3 and Table 1). In the in vivo model, when compared
with genes expressed in cell culture, with the exception
of the group of unknown, hypothetical and conserved
hypothetical proteins (44 % of in vivo induced genes), the
largest group of functional category genes (HEGCIFPQ)
and pathways showing increased expression belonged to
the metabolism group (Fig. 3, Table 1). In contrast, fewer
genes and pathways involved in metabolism were up-
regulated in the cell-free culture model than in the cell
culture model. Apart from the metabolic genes, other
genes seen to be highly up-regulated in vivo when com-
pared to cell culture belonged to defence mechanisms (V),
cell wall biogenesis (M) and recombination and repair (L)
categories probably due to bacterial resistance to the harsh
environments of PV. In cell-free culture 16 % of induced
genes belonged to translation (J) and post translational
modifications/protein-turnover (O) categories indicating
more protein synthesis leading to faster growth rates com-
pared to other conditions.
To gain insight into the distribution and uniqueness of
regulated genes in the different culture models, Venn-
diagrams were constructed (Fig. 4). Comparison of dif-
ferentially regulated genes under in vivo conditions and
Fig. 2 Hierarchical clustering analysis on normalised signal intensities of probes of 602 and NM strains in different culture models. Data shows
clustering of in vivo and in vitro models separately based on patterns of gene expression. Normalised signal intensity (log2) of probes (average
of triplicates) for each condition are represented as a colour scale from red for high expressions to blue for lower expressions. In vivo (M =mice
spleen), cell culture (cc), cell-free adapting phase passage 1 (p1) and passage 2 (p2), cell-free culture model (cf)
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cell-free culture (including p1, p2 and cell-free adapted)
with respect to cell culture showed 176 genes which
were similarly regulated between different models and a
large number of genes (366 genes) which were specifically
regulated in vivo (Fig. 4). These data suggest that gene ex-
pression of C. burnetii under in vivo conditions is quite
different from its in vitro culture models.
Among the in vitro models, comparison between p1
and p2 cultures resulted in differential regulation of
0.6 % of genes only, suggesting that these cultures were
highly similar. Comparison of p1 and p2 cultures with
cell-free adapted and cell culture showed differential
regulation of 15 and 30 % of genes respectively. This in-
dicates that based on the transcriptomic profiles, p1 and
p2 cultures are closer to cell-free adapted culture than
those from cell culture. The 15 % of genes that were dif-
ferentially regulated in p1 and p2 compared to cell-free
culture were further categorised into functional groups.
About 40 % of these differentially regulated genes in p1
and 30 % in p2 were involved in metabolism categories
(CEFGHIPQ), showing almost a 10 % decrease in metab-
olism related genes in p2 within 1 passage, itself in a
cell-free environment. This shows that p1 and p2 cul-
tures regulate the genes in a way similar to adapted
cell-free culture, most likely due to available resources
in the culture media. Thus, the rapid adaptation cap-
abilities of C. burnetii were seen when moved from one
environment to another.
Fig. 3 Functional COG-categories of differentially regulated C. burnetii genes under in vivo and in vitro culture models. Functional categories of
regulated genes of the 602 strain under in vivo and cell-free culture compared with cell culture model. The up-regulated and down-regulated
genes are shown on the right and left side of the y-axis respectively. Largest group of regulated genes in all culture models belonged to the
unknown function category (S). Large number of up-regulated genes under in vivo conditions belonged to the metabolism group such as coenzyme,
carbohydrate, amino acid and lipid transport and metabolism (HGEI). Whereas, the largest number of up-regulated genes in cell-free culture compared
to cell culture belonged to the protein synthesis group (O)
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C. burnetii requires metabolic adaptations for different
culture models
Striking differences were found between in vivo and in
vitro culture models in metabolic pathway regulation.
These differences could be attributed to the type of nu-
trient the bacteria were able to use for metabolism.
Under in vivo conditions, genes implicated in glucose
transportation (CBU0265), phosphorylation and glycolytic
intermediates generation were up-regulated compared to in
vitro models [29]. Further, the terminal enzymes of the
glycolytic pathway were repressed and genes implicated in
phospholipid synthesis were induced, indicating the use of
glycolytic intermediates for phospholipid synthesis (Fig. 5a).
Among the different phospholipids [30], gene encoding car-
diolipins (cls), an anionic phospholipid were highly induced
in vivo compared to in vitro conditions, indicating an
increased synthesis of cardiolipins allowing the bacterium
to survive in the highly acidic environment of spleen cell
PV [31]. A low level expression of cls in cell and cell-free
cultures might be sufficient for the bacterium to sustain
under in vitro environments, while up-regulation in vivo is
possibly required to cope with specific in vivo conditions
associated with the acidic environment. In a previous
study, cardiolipids were not identified by biochemical ana-
lysis of phospholipids in C. burnetii grown from in vitro
embryonated eggs [32], implying its greater importance
under in vivo conditions. These data confirm previous re-
search indicating that the phospholipid content of micro-
organisms can differ based on the bacterial environment
in order to cope with new environmental conditions [33].
Genes implicated in the synthesis of lipids were enhanced
in vivo more than under in vitro conditions. Enhanced
Table 1 Significantly regulated (KEGG) Pathways in different culture models of C. burnetii
Pathway ID Pathway m vs. cc p1 vs cc p2 vs. cc cf vs cc
Metabolic pathways
cbu00230 Purine metabolism 5.20E-18* 2.00E-01 5.40E-06* 1.10E-12*
cbu00010 Glycolysis/Gluconeogenesis 1.00E-13* 3.80E-03* 1.50E-07* 1.50E-07*
cbu00190 Oxidative phosphorylation 3.10E-10* 2.40E-01 1.90E-02* 1.30E-01
cbu00240 Pyrimidine metabolism 5.20E-06* 9.80E-03* 1.80E-08* 5.60E-05*
cbu00564 Glycerophospholipid metabolism 1.80E-05* 6.30E-02 6.00E-02 6.80E-02
cbu00020 Citrate cycle (TCA cycle) 9.20E-04* - 3.40E-02* 5.30E-02
cbu00071 Fatty acid metabolism 3.10E-03* - - -
cbu00061 Fatty acid biosynthesis 3.20E-03* 1.40E-02* 7.40E-02 7.90E-02
Biosynthesis of secondary metabolites
cbu00900 Terpenoid backbone biosynthesis 2.80E-05* - - -
cbu00780 Biotin metabolism 1.00E-04* 1.00E-03* 2.30E-03* 2.40E-06*
cbu00730 Thiamine metabolism 6.10E-04* 7.90E-03* 9.80E-03* 1.30E-05*
Biosynthesis of amino acids
cbu00400 Aromatic amino acids biosynthesis 8.40E-08* - - -
cbu00250 Alanine, aspartate and glutamate metabolism 3.40E-05* - 2.30E-02* 1.20E-03*
cbu00260 Glycine, serine and threonine metabolism 2.20E-04* 1.60E-04* 2.30E-06* 1.10E-04*
Virulence
cbu00540 Lipopolysaccharide biosynthesis 5.40E-10* 2.80E-04* 3.70E-05* 1.90E-04*
cbu03070 Bacterial secretion system 7.40E-08* 6.90E-02 - 1.30E-03*
Repair mechanisms
cbu03430 Mismatch repair 7.90E-13* - 3.60E-06* 1.50E-17*
cbu03410 Base excision repair 1.00E-07* - 3.40E-02* 2.50E-05*
cbu03420 Nucleotide excision repair 8.00E-07* - - 4.50E-02*
Others
cbu00550 Peptidoglycan biosynthesis 4.00E-13* - - 3.30E-03*
cbu02010 ABC transporters 1.00E-04* - 4.00E-02* 1.10E-03*
cbu02020 Two-component system 3.50E-03* - - -
The P value (adjusted by Benjamini-Hochberg method) of regulated pathway is shown for each comparison of 602 strain. Significant pathways (p < 0.05) are
depicted with *. In vivo (m =Mice spleen), cell culture (cc), cell-free adapting phase passage 1 (p1), cell-free adapting phase passage 2 (p2), cell-free culture
model (cf)
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expression of a putative long-chain fatty acids trans-
location gene (CBU1242) across the outer membrane of
the bacterium was seen, indicating its abundant pres-
ence in the PV of host spleen cells. Interestingly, genes
coding de novo synthesis of fatty acid were also in-
duced, probably to synthesize more fatty acids to meet
the overall requirements of the bacterium. The data
shows C. burnetii can acquire lipids through both de
novo bacterial synthesis as well as by subversion of host
cell pools as indicated previously [30]. Further, the
mevalonate pathway, which encodes an isoprenoid back-
bone (Fig. 5b), [24, 34] and other genes (uppS, ispB) that
use isoprenoids as substrates were up-regulated in vivo
and might help C. burnetii in cell wall synthesis and nor-
mal growth in host cells [35, 36]. Apart from synthesis of
its own lipids, it has been speculated that C. burnetii can
use host cell cholesterol precursors and convert these into
cholesterol. The genome of C. burnetii encodes putative
Δ24 sterol reductase (CBU1206) the biological role of
which is not known, but in general are involved in final
stages of cholesterol synthesis in eukaryotic cells. Main-
taining such a unique gene in its genome and its up-
regulation suggests a critical function for this gene in the
bacterium in vivo [37–39]. The role of cholesterol in bac-
terial pathogenesis is unclear [40, 41], and cell culture of
C. burnetii lacking cholesterol showed either no effects
or negative effects on replication and PV morphology
[38, 39]. Sterol reductase could be involved in cholesterol
synthesis in limiting sterol conditions. However, since
mammalian cells have a high sterol content, the bacteria
would not need to synthesize more cholesterol. It is more
likely that up-regulation of sterol reductase is involved in
generating novel sterol species that have signalling, struc-
tural roles or associated with oxidative stress responses
[30, 40–43]. Within in vitro models, induction of these
genes was seen in cell culture at lower levels than ob-
served in the in vivo system, indicating that the synthesis
of these lipids is only intracellular.
The size of the genome of C. burnetii is highly reduced
(around 2 Mb) comparable to size in other obligate
intracellular pathogens. This renders C. burnetii auxo-
trophic for several amino acids or causes it to lack key
enzymes in several biosynthetic pathways [24]. Yet under
in vivo conditions, several amino acid and oligopeptide
transporters, pathways implicated in synthesis of aro-
matic amino acids (Fig. 5c) [24, 44, 45] and degradation
of amino acids (L-serine, L-aspartate, L-glutamine, L-
cysteine, L-methionine, L-proline) were highly induced.
Taken together, these observations suggest that C. bur-
netii can acquire several amino acids from hosts and
synthesizes a few that may be in limited supply due to
severe nutritional stress in host cells. A lower level of
nutritional stress can be inferred in in vitro conditions,
since compared to in vivo only a few transporters are
up-regulated in cell culture (CBU1798, CBU0539) and
cell-free culture (CBU1130, artM).
A large number of genes coding several co-factors
(biotin, thiamine, folic acid and Coenzyme A) was also
up-regulated in vivo relative to in vitro culture models
(Fig. 5d, e). The high level expression of these genes im-
plicated in co-factor synthesis, might indicate lack of
readily available co-factors in the spleens of mice. Con-
trary, it could be possible that the C. burnetii genome
might not encode co-factor transporters and therefore
Fig. 4 Venn diagram of differentially expressed genes of 602 strain in different culture models. Comparison of differentially regulated genes
under in vivo, cell-free adapting serial passages (p1 and p2) and fully adapted culture with respect to in vitro growth in cell culture
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Fig. 5 (See legend on next page.)
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synthesizes them since they are required for growth
under in vivo conditions. The cell and cell-free culture
media are rich in co-factors and down-regulation of
pathways involved in co-factor synthesis; imply transpor-
tation of co-factors by the bacterium. As of now, specific
co-factor transporters for these organic co-factors are
not reported, but C. burnetii encodes several generic
transporters in its genome which could potentially trans-
port these co-factors that are crucial for several enzyme
reactions involved in amino acid, glucose, lipid metabolism
or the regulation of genes.
As the fatty acid degradation pathway was up-regulated
in vivo, catabolism of fatty acids appeared to play an im-
portant role in energy metabolism. Among the genes im-
plicated in this pathway, the yfcX gene was most strongly
induced (Fig. 5f). This results in anaerobic degradation of
long/ medium chain fatty acids and produces NADH as a
major cofactor for energy generation [46]. Genes involved
in carbohydrate metabolism (dehydrogenases such as
pdhA, pdhC, lpdA, sucB, sdhA, sdhC) were repressed
under in vivo conditions, indicating an abundance of fatty
acids (and fewer carbohydrates) in host cells. In cell and
cell-free cultures these carbohydrate metabolism genes
were enhanced, suggesting oxidation of glycolytic and
TCA intermediates for energy production. The Cyto-
chrome bd oxidase gene (cydA) was highly induced under
in vivo conditions but at lower levels in cell culture, indi-
cating an increased affinity for oxygen under intracellular
conditions [47]. These differences suggest that the kind of
nutrients found in the environment affects pathogen
manipulation.
In conclusion, under in vivo conditions, the transpor-
tation of organic nutrients was up-regulated, showing in-
creased dependence of the bacterium on host-derived
products. In vivo, the bacteria also shows enhanced
biosynthetic capacities, which are directed to fulfill
metabolic requirements that are unavailable directly
from the host. In contrast, in vivo the bacterium represses
a majority of genes coding for nucleotide synthesis and ri-
bonucleotide reductases, which could be connected to the
slow replication rate observed compared to in vitro cul-
ture conditions. Within in vitro cultures, gene regulation
in cell culture were similar to in vivo but at much lower
mRNA levels, indicating similar intracellular metabolic
adaptations. Hence anaerobiosis, nutrient limitations,
inaccessibility of co-factors were prominent environmental
conditions encountered by C. burnetii during growth
in vivo in the mice spleens.
Enhanced regulation of transporter systems in hosts
Bacterial transporters import essential nutrients, but are
also used to import physiological substrates and export
toxic molecules, both critical for cell viability, pathogenicity
and virulence [48]. Under in vivo conditions, many trans-
porters encoded by C. burnetii due to its intracellular life
style were probably induced to maintain homeostasis [24].
Among these transporters are, sodium ion/proton ex-
changers (shaE, shaA, nhap.1), which might play a vital role
in bacterial cytoplasmic pH homeostasis within the acidic
PV. Several predicted drug-efflux systems (CBU0804,
CBU0048, CBU0833, CBU1808, CBU1809) were enhanced,
providing resistance and removal of toxins and host defen-
sins. Among the metal transporters, gene implicated in in-
organic phosphate transport were strongly up-regulated
(CBU0014) under in vivo conditions along with up-
regulation of phosphate starvation-responsive loci phoBR,
which is one of the few two-component regulatory system
present in C. burnetii. Under phosphate starvation, en-
hanced expression of ATP producing genes was observed,
possibly due to increased ATP demand caused by a limited
amount of available phosphate [49].
High degree of oxidative stress in host cells
The generation of oxidative stress agents, which damage
key bacterial components, is an innate defense response
of host phagocytic cells. Strategies used by C. burnetii to
avoid reactive substances mainly involve the enzymatic
destruction of radicals and DNA repair mechanisms.
Among ROS scavenging systems, peroxiredoxin (ahpD)
and its response regulator (oxyR) genes were enhanced
under in vivo conditions. Other ROS scavenging enzymes
such as functional catalase (KatE) are present in only few
C. burnetii strains. Presence or absence of a functional
catalase gene in 602 was assessed by mapping its genome
sequences against a strain containing a functional catalase
gene (Cbuk_Q154, Accession number: NC_011528.1) as
shown previously [15]. The genome sequences of 602
showed the presence of a highly truncated catalase gene as
in NM [50]. The absence of a functional catalase gene in
602 and NM might be compensated by peroxiredoxins,
which were enhanced under in vivo hosts. Under in vitro
conditions, other ROS scavenging enzymes were enhanced
(See figure on previous page.)
Fig. 5 Some metabolic pathways and pathways implicated in virulence and repair mechanisms induced in vivo compared to in vitro cultivation.
The pathways were drawn according to KEGG database. Circles next to each gene display its regulation for each condition. a–i represent significantly
up-regulated KEGG pathways under in vivo conditions: a Cardiolipin synthesis, b Mevalonate pathway, c Tryptophan synthesis, d Biotin synthesis,
e Thiamine synthesis, f Fatty acid degradation, g Base excision repair, h Nucleotide excision repair, and i LPS synthesis. Reactivity of in vivo vs
cell and cell-free cultures are always the same (except cbu0608, due to induction of mevalonate pathway in cell culture similar to in vivo, relative to
cell-free culture system)
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in cell culture (ahpC1, ahpC2) and cell-free culture (sodC),
thus indicating an increased peroxidase presence in intra-
cellular hosts and superoxide radicals in the extracellular
cell-free system. An induced protein synthesis was ob-
served in the cell-free system, possibly leading to en-
hanced expression of the glutathione pathway, which
restores protein function by reducing oxidized residues.
Genes implicated in DNA repair (base excision repair,
methyl mismatch repair and nucleotide excision repair)
were strongly enhanced under in vivo conditions and
collectively repair various DNA damages caused by oxi-
dative stress (Fig. 5g, h) [51–55]. Also the upregulation
of addAB genes was seen; this is a novel adaptation of
C. burnetii in its intracellular niche, which mediates
DNA repair via homologous recombination [56]. Thus
enhanced expression of DNA repair was seen in vivo
and at relatively lower rate in cell culture, indicating
bacterial response to increased oxidative stress in intra-
cellular environments.
Induction of virulence genes in vivo
Among the known virulence factors, lipopolysaccharides
(LPS) are considered to be the major determinant of the
virulent phenotypic expression and infection of C. burnetii.
Most likely the LPS shields the bacterial cell surface from
innate immune recognition [57, 58] and/or the LPS phase-
II works as an immunological decoy. Genes encoding struc-
tural features of LPS such as lipid A, the core region and
the cluster of genes involved in O-antigen synthesis were
enhanced under in vivo conditions compared to in vitro
systems (Fig. 5i) [59]. ABC transporters implicated in
lipid A (MsbA) and O-antigen (CBU0703) transport were
strongly induced, indicating the export of LPS compo-
nents to the outer membrane, where it plays an important
role in bacterial virulence [59, 60]. Within the in vitro
models, the p1 and p2 cell-free cultures showed similar
level of regulation of O-antigen genes as in cell-culture,
whereas the adapted cell-free culture (passage n > 10)
showed a significant down-regulation of these genes, due
to their deletion resulting in an on-going transformation
into phase II forms [15]. Occurrence of phase II forms
through the functional deletion of O-antigen coding genes
might be an advantageous feature in the bacteria, allowing
it to conserve the metabolic energy required to synthesize
complex polysaccharides [61] and instead use energy for
other important processes, such as growth or protein
synthesis. This would be consistent with the enhanced
expression of LPS genes seen in C. burnetii under in vivo
conditions, and may be important during infection and in-
crease in adaptation capabilities of the bacterium in hosts.
Moreover, modifications in transcriptome of C. burnetii
were seen only in the O-antigen region of high passaged
cells, which might possibly result in reduced virulence
potential.
Among the other virulence factors “Type IV secretion
systems” (T4SS) have been identified as one of the im-
portant transfer systems in C. burnetii that delivers bac-
terial effector proteins into the host cytosol and are
intimately involved in the pathogenesis of the bacterium.
Genome sequencing has revealed the presence of an intact
T4SS homologous to L. pneumophila Dot/Icm system. To
date, only this system has been shown as a virulent deter-
minant essential for the creation of vacuole, establishing a
niche for intracellular survival and replication of the bac-
terium in eukaryotic host cells [24, 62–66]. Previous tran-
scriptional studies on Dot/Icm system in C. burnetii has
shown high expression of these genes during early stage
infections [67, 68]. Under in vivo conditions, the expres-
sion of Dot/Icm genes along with their transcription regu-
lator (pmrA) were repressed with respect to in vitro
models, probably due to later stages of growth of the bac-
terium in vivo where the infection has already taken place
and the function of these genes had already been exerted,
resulting in the establishment of replicative vacuole and a
productive infection. Although, the transcription of these
genes is repressed in later infection stages, decreased pro-
tein levels are maintained constantly [68]. Hence secretion
of effector proteins of the T4SS required for maintaining
an intracellular niche is still possible in the host cells.
Under in vivo conditions, T4SS effector proteins such as
ankyrin repeat domain containing proteins (ankC, ankG)
were up-regulated, and have been shown to interfere with
the host cell apoptosis pathway [69]. Other effector pro-
teins encoded by plasmid genes (CBU0014, CBU0015,
CBU0006) were also up-regulated. These proteins are de-
livered by T4SS into host cytosol and might play a role in
subversion of host cell functions [70]. Under in vitro con-
ditions, the T4SS was up-regulated. In cell culture, this
system must be enhanced as the bacteria emerging from
PV can re-infect new cells in the culture. Interestingly, this
system was also seen to be enhanced in cell-free culture,
although the bacterium does not require it as the medium
is devoid of cells. Hence, the cell-free in vitro environment
might induce the full repertoire of transcriptional responses
required for successful pathogenesis of the bacterium
for future challenges and transmission.
Others predicted virulence factors implicated in the
manipulation of host-cell components and processes were
also relatively enhanced under in vivo conditions. Among
these were putative genes encoding phospholipase A
(CBU0489) which can act on host phospholipids and gen-
erate lipid signaling [50, 71], acid phosphatase (CBU0335)
which can phosphorylate host proteins and decreases oxi-
dative burst after phagocytosis of the bacterium [67], pro-
teins with eukaryotic like domains (CBUA0014, CBU2078)
which can modulate host ubiquitination pathways and
disrupting host cell processes during infection [72, 73]
and other eukaryotic like protein kinases similar to STPKs
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(CBU0175, CBU1379) which can directly interfere in host
cell signal transduction [50, 74]. Hence, strong regulation
of genes involved in manipulating and functionally mim-
icking the activity of host cell proteins was seen as a viru-
lence property of the bacterium in hosts.
Stringent responses of C. burnetii in hosts
Under environmental stress (such as the intracellular
in vivo conditions), bacterial species show stringent
responses to escape unfavorable conditions. Under in
vivo conditions, genes implicated in alarmone degrad-
ation were regulated (down-regulation of spoT and up-
regulation of relA) which results in accumulation of
unusual guanosine nucleotides (p)ppGpp, a hallmark of
stringent response in several bacterial species [75]. In
several bacterial species stringent responses were
shown to play a role in sporulation, virulence and long-
term persistence, usually in response to environmental
stress [75, 76]. For example, in L. pneumophila, a close
relative of C. burnetii, the stringent pathways are im-
portant factors in modulating the virulent attributes
that help its survival in the host [77]. The role of these
regulatory networks in C .burnetii is not known yet and
differential regulation of these genes under in vivo con-
ditions at later infection stages (Day 20) may result in a
greater benefit to the survival of the bacteria, which
would be an interesting area of study in need of further
investigation.
Additional microarray experiments performed in par-
allel with NM reference strain revealed similar gene ex-
pression patterns in vivo compared to in vitro models
(data not shown) indicating that the trends described by
the Dutch 602 outbreak field strain are likely to prove
relevant to other C. burnetii strains more generally.
Therefore, the microarray data increases our knowledge
regarding pathogen adaptation to host micro environ-
ments, selective pressures in these environments and
bacterial factors responsible for evading host responses.
Finally, the microarray data can be used as a guide to
screen and select genes encoding putative membrane
proteins and other proteins that have antigenic proper-
ties among the differentially regulated genes during vary-
ing conditions. This might provide a framework for new
possibilities to investigate and identify virulent factors
important in the design of vaccines.
Conclusions
This is the first report on C. burnetii genome-wide tran-
scriptome profiles isolated from in vivo and in vitro cul-
ture models. The data provide insight into pathways
associated with bacterial adaptation to varying environ-
mental conditions and identify potential virulent factors
based on the mRNA levels of genes measured by micro-
array approach. Transcriptome differences in C. burnetii
were profound between in vivo and in vitro culture
models. Within the in vitro culture systems, the expres-
sion profile of C. burnetii from cell culture were closely
related to expression profiles from the in vivo model
(Fig. 2). This might be due to its intracellular nature and
low nutrient availability in cell culture compared to free
availability of nutrients in the more artificial cell-free
culture model. The cell-free culture adapting passages
(p1 and p2) expression profiles migrated towards cell-free
adapted strains indicating the ability of the bacterium to
adapt promptly to available resources in the environment.
Between the different models, major differential gene
regulations was primarily observed in metabolic processes
of the bacteria. Under in vivo conditions, the exciting ob-
servations in our study were; enhanced expression of an-
ionic phospholipid coding gene (cls) for maintenance of
acidic pH at outer membrane surface; organic molecule
transportation indicating non-starvation of the bacteria;
phosphate limitation as an important intracellular signal,
and enhanced DNA repair mechanisms to combat against
oxidative stress in host cells. We have also been able
to provide evidence that based on the observed gene-
regulation, lipids play a very important role in several
biosynthetic processes of C. burnetii in vivo and are
the primary sources for anaerobic energy metabolism,
possibly due to their abundant presence in mice spleens.
However, carbohydrate metabolism was observed under in
vitro culture systems indicating type and availability of nu-
trients were important determinants for resulting expres-
sion patterns of C. burnetii in different models. Relative to
in vitro conditions, the in vivo environment significantly
enhanced expression of virulence genes such as LPS-linked
genes and factors implicated in host-cell modulations (in-
hibition of apoptosis, evading defense mechanisms etc.).
This capability to modulate host response to infection
seems to be a key factor for C. burnetii survival in vivo.
Methods
Bacterial strains and culture models
C. burnetii strain 602 was isolated from aborted placenta
of goats during a Q fever outbreak and initially propa-
gated on Buffalo Green Monkey (BGM) cells (European
Collection of Cell Cultures, Salisbury) as described pre-
viously [15, 20]. The strain was genotyped by MLVA as
CbNL01, a predominant genotype during the outbreak.
The 602 and Nine Mile RSA493 (NM) reference strain
were propagated in different models explained below.
Mice spleen model
The spleens from mice infected with C. burnetii 602 and
NM strains were used as in vivo model to study bacterial
gene expressions. Animal experiments were conducted
using 7 week old Specific-Pathogen-Free Swiss female OF1
mice (Charles River, l’Arbresle). The mice were housed
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under sterile conditions in biosecurity level 3 facilities. After
a week of acclimatization, infections were performed with 3
Swiss OF1 mice per strain. The mice were inoculated intra-
peritoneally with 0.2 ml PBS suspension of C. burnetii
(grown in BGM cell culture) with each mouse receiving a
dose of 107 genome copy equivalents as determined by
quantitative PCR [20]. Twenty days after inoculation
the mice were euthanized, spleens were harvested aseptic-
ally and immediately frozen in liquid nitrogen and then
at −80 °C for RNA isolation. Animal experiments were
approved by the animal experiment commission of the
Central Veterinary Institute part of Wageningen UR,
and conducted in accordance with the Dutch regula-
tions on animal experimentation.
In vitro culture models
The C. burnetii strains used in the study were propagated
in cell and cell-free cultures in triplicate from the low pas-
sage stock cultures stored at −80 °C.
Cell culture model
For the cell culture model, BGM cells with EMEM culture
media without antibiotics (10 % bovine serum albumin, 1 %
NEAA, 1 % glutamax) were used to propagate C. burnetii
from stock cultures (passage n = 10–12 in BGM cell
culture) until stationary growth phase [20].
Cell-free culture model
For the cell-free culture, the protocol previously de-
scribed [23] was used to propagate C. burnetii (passage
n = 10–12 in cell-free culture) until stationary growth
phase. Two serial passages (p1 and p2) of the strains
from cell to cell-free culture model were also performed
in addition and were included in the study.
C. burnetii specific RNA isolation
The frozen spleens were thawed on ice and a piece of
the tissue was homogenized (PowerGen 125, Fischer Sci-
entific, Pittsburgh) in trizol reagent (Ambion, Austin)
with a disposable plastic micro pestle (OMNI-Tip plastic
homogenizing probes, OMNI international, Kennesaw)
and used for RNA isolation. The in vitro cell culture
supernatants were centrifuged at 1200 rpm, 4 °C for
10 min to remove cell debris. These processed superna-
tants of cell and the cell-free cultures were centrifuged
at 16,000 rpm, 4 °C for 30 min to pellet the bacterial
cells and subsequently treated with trizol for RNA isola-
tion. Total RNA was isolated by using Direct-zol RNA
MiniPrep Kit (Zymo Research, Irvine) as per manufac-
turer’s instructions. All samples were DNAse treated
prior to RNA isolation. The host RNA from total
spleen RNA were selectively removed by MICROBE-
nrich kit (Ambion, Austin) followed by RNA clean and
Concentrator-5 kit (Zymo Research, Irvine) for RNA
clean-up and concentration.
C. burnetii specific microarray
Custom gene expression microarrays, 8×15 K, designed
by Agilent (Agilent Technologies, Santa Clara), consisted
of eight arrays per slide with duplicates of 7500 probes.
All the probes were user-designed by eArray web-based
probe design tool (https://earray.chem.agilent.com/ear-
ray) based on the complete gene repertoire of C. burnetii
(NCBI, Accession numbers: AE016828.2, CP000733.1,
CP001020.1, CP001019.1, CP001021.1 and draft genomes
of Dutch C. burnetii strains). 1 to 4 probes of 120 bp in
length were designed per gene such that the probes evenly
distributed across the gene.
RNA amplification, labelling and hybridization
Poly A tails were tagged to purified bacterial total RNA
(500 ng) from all the culture models with a Poly A Poly-
merase Tailing kit (Epicenter Illumina company, Madi-
son) as per manufacture instructions. Poly A tailed RNA
(250 ng) were prepared for amplification and labelling
using the Low Input Quick Amp Labeling Kit from Agi-
lent following the detailed kit protocol. Cyanine 3–labelled
cRNA was purified using RNeasy mini kit (Qiagen, Hil-
den). Labelled cRNA was examined with the Nanodrop
ND-1000 (Thermo Fisher Scientific, Wilmington) to as-
sess its concentration and quality. Hybridization and
post-hybridization washes were conducted according to
Agilent’s one-color microarray-based gene expression
analysis protocol (Version G4140_90042).
Data and statistical analysis
Microarray slides were scanned using a Surescan High
Resolution DNA microarray scanner (Agilent Technolo-
gies, Santa Clara). Data was obtained through Agilent’s
feature extraction software (Version 10.7.3.1) and loaded
in Genespring GX (Version 12.6.1) where signal intensity
was log2-transformed and median normalized for all
triplicate samples before analysis. PCA plots (based on
correlation coefficients obtained from pair-wise compari-
sons of samples) and clustering of microarray data (based
on Euclidian distance and Ward’s linkage parameters)
were analysed using Genespring GX to display relative dif-
ferences across samples. Differentially regulated genes be-
tween different culture models were determined by 2-way
ANOVA (p < 0.05, adjusted by the Benjamini and Hoch-
berg false discovery rate algorithm) and a cut-off of 2 for
the fold change was identified as significantly differential
expression. These differentially regulated genes from
different comparisons were plotted by means of a Venn
diagram using Vennerable package (Version 2.0). David
(http://david.abcc.ncifcrf.gov/) and KeggArray software
(http://www.genome.jp/kegg/) was used for pathway
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analysis and to obtain P values of significantly regu-
lated pathways for each comparison of 602 and NM
strains against Coxiella burnetii RSA 493 (organism
code: cbu) KEGG pathway database.
Additional files
Additional file 1: Figure S1. Changes in splenomegaly and bacterial
genome equivalents present in the spleens of mice infected with 602
and NM C. burnetii strains at 7 and 20 days p.i. A) Bacterial genome
equivalents of total spleens are evaluated by qPCR quantification and
expressed as log2 transformed values, B) Degree of splenomegaly are
expressed as the percentage of spleen weight compared with the body
weight. The results are indicated as means ± standard deviation, * indicates
p-values smaller than 0.05. (TIFF 265 kb)
Additional file 2: Table S1. List of genes differentially regulated in vivo
and cell-free culture with respect to cell culture in vitro model of 602
strain, after passing statistical significance filter and showing more than
two fold change in expression. All the genes are arranged based on COG
functions. A positive value indicates that the gene is up-regulated, a
negative value indicates that the gene is down-regulated and – indicates
no difference compared to cell culture in gene regulation under the
respective condition. (XLSX 204 kb)
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